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ABSTRACT: Clinicopathologic features of a case of lymphoblastic lymphoma (LyLI with the classic 14;18 
translocation are described in this article. The patient had prominent splenomegaly with 
numerous plenic nodules, exhibiting a homogeneous blast (:el/infiltrate and occasional cells 
with cleft nuclei, a picture suggestive of high-grade non-Hodgkin lymphama (NHL) possibly 
lymphoblastic, Early B-cell features were detected immunologically, thus confirming the diagno- 
s•s of LyL. The presence (ff primary splenic involvement and of the t(14;181fq32;q211 areun- 
usual in this histologic subset of B-cell Nt IL, these cytogenetic and clinicopathologic characteris- 
tics being typically associated with low- or intermediate-grade NHL of follicle center origin. 
These features, along with the presence of some centrocytelike cells in the biopsy sections, 
suggest that an unusual pattern of histologic evolution from u follicle center ('ell NIIL may have 
occurred in this case of LyL. 
INTRODUCTION 
Lymphoblastic lymphoma (LyL) is a morphologically distinct entity of non-Hodgkin 
lymphoma (NHL) [1] with aggressive clinical behavior. Both T-cell and B-cell pheno- 
types have been documented, the former immunologic subset frequently involving the 
mediastinum, the latter presenting with prevalent abdominal disease [2]. Cytogenetic 
studies were performed in a l imited number of patients, showing 14ql l  re- 
arrangements and other less frequent abnormalities, besides normal karyotypes [3, 4]. 
We recently observed a patient with typical B-cell LyL presenting with prominent 
splenomegaly and showing the classical t(14;18)(q32;q21) asthe sole aberration. These 
unusual cytogenetic and cl inicopathologic findings are here il lustrated and discussed 
with regard to their possible significance in terms of origin and evolution of this rare 
form of NHL. 
CASE HISTORY 
The patient, a 71-year-old man, was referred to our institution with fever, weight 
loss, and splenomegaly-related symptoms. Phy ical examination was unremarkable, 
except for marked spleen enlargement. A chest x-ray film was normal. A computed 
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Figure 1 Histologic: preparation showing diffuse infiltrate by lymphoblasts with some macro- 
phages. Some cells with cleft nuclei are arrowect. 
tomography (CT) scan of the abdomen revealed numerous plenic nodules, one of 
which involved the il ium structures. At laparotomy, omental infiltration was docu- 
mented, and multiple biopsies were obtained showing on frozen sections a monomor- 
phic blast cell infiltrate, a picture suggestive of high-grade NHL. Bone marrow (BM) 
smears, as well as trephine biopsy sections, documented the absenc:e of infiltration 
by lymphoma cells. Multiagent chemotherapy {cyclophosphamide, vincristine, daun- 
orubicine, and prednisone} was administered monthly, and partial reduction of the 
spleen size was obtained. The patient is alive after 6 months, but his clinic:al condition 
has deteriorated (Karnowsky score, 60). 
MATERIALS AND METHODS 
Histologic Studies 
A section of the biopsy specimen was sent to the pathologist for classification ac- 
cording to the Kiel system [5]. Histologic preparations were made from formalin-fixed 
material and were stained with hematoxylin-eosin, Giemsa, periodic acid-Schiff, and 
Gomori's silver impregnation. 
Immunophenotyping 
A piece of the diagnostic: tissue was minced into RPMI 1640 in sterile conditions 
immediately after surgical removal. An aliquot of the cell suspension, adjusted to the 
concentration of I × 106/ml was spun onto a cytocentrifuge, and slides were processed 
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Table 1 hnmunophenotype of neoplastic 
cells a 
Monoclonal 
antibody % Positive cells 
B4/CD19 92 
JS/CD10 87 
Ig 
Mu Negative 
Kappa Negative 
Lambda Negative 
TdT 56 
C3bR/CD35 6 
Leul/CD5 Negative 
OKT16/CD7 Negative 
Kil/CD30 Negative 
OKT26a/CD25 Negative 
HPCA1/CD34 45 (weak) 
o Determined by APAAP technique (100 cells observed 
on cylospin preparations). Results were confirmed by 
immunohistochemical st inings showing positivity for 
the L26 associated B-cell antibody, positivity in a slight 
minority of cells for the I..N2 antibody and negativity for 
surface and cytoplasmic immunoglobulin chains. 
according to the APAAP technique [6]. The expression of the following markers 
was tested: CD19, CDIO, CD5, CD2, HLA-Dr, CD33, and surface and cytoplasmic 
immunoglobulins (Ig) (heavy and light chains). 
Immunohistologic stains were also performed on paraffin sections with the follow- 
ing murine antibodies: UCHL 1 (CD45), L26 (detecting a pan-B cell antigen) (Dako), 
LN1, LN2, LN3 (detecting antigens associated with germinal center cells) (Biotest 
Diagn.) and anti-kappa, anti-lambda, anti-mu, anti-gamma and anti-alpha immuno- 
globulin chains. The presence of intracytoplasmic immunoglobulin chains on histo- 
logic sections was tested with the peroxidase-antiperoxidase method [7]. 
Cytogenetic Analysis 
For cytogenetic analysis, 5 x 106 cells/ml were cultured in RPMI 1640 additioned 
with 10% fetal calf serum (Gibco), and 50-mi flasks were incubated at 37°C in 5% CO2 
humidified atmosphere. Cells were harvested according to standard procedures [8] 
after 24 hours. 
RESULTS 
The typical morphologic features of LyL [9] were observed on histologic sections. The 
cells had a fine chromatin pattern, and cytoplasm was scanty. Cleft nuclei were only 
observed occasionally (Fig. 1). As shown in Table 1, immunophenotype was that of 
a very immature B cell with negative cytoplasmic and surface Ig chains. Cytogeneti- 
cally, the classical t(14;18)(q21 ;q32) was the sole aberration i  18/20 metaphases (Fig. 
2). Two cells had a normal karyotype. 
DISCUSSION 
In this reported patient, morphologic features and immunophenotype of neoplastic 
cells were typical of B-cell LyL [10]. Unlike previously reported cases, however, the 
clinical presentation was consistent with the occurrence of primary splenic involve- 
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Figure 2 Partial karyotypes showing the classical t(14:18)(q32;q21) in our patient with LyL. 
No additional clonal aberrations were detected in this patient. 
ment. LyL with prominent splenomegaly has not been rei)orted in the largest pub- 
lished series [2, 10, 111, and the most frequent histological types encountered in 
primary splenic NHL are represented by low- and intermediate-grade NHL, including 
follicle center cell lymphomas, intermediate lymphocytic lymphoma (included 
among the centrocytic type in the Kiel system), and small lymphot:ytic lymphoma 
[12, 13]. 
The presence of the 14;18 translocation as the sole aberration in our patient is 
remarkable, since previous tudies have not detected this aberration in Lyl, [3, 4, 14]. 
However, some patients have recently been reported in which unusual evolution of 
low-grade follicle center cell NHL into high-grade Burkittlike histology were docu- 
mented [15, 16]. In one such case, immunophenotyping revealed, as in our patient, 
immature B-cell features, and cytogenetic analysis of BM lymphoma cells at the time 
of blastic conversion showed a 14;18 translacation variant as well as the classical 
t(8;14). 
While no residual nodular structures were observed in our biopsy sections, some 
cells had cleft nuclei, a feature suggestive of a possible follicle center cell origin. Thus, 
indirect evidence, based on the cytogenetic findings and on the clinical presentation, 
seems to suggest hat histologic evolution from a follicle center cell lymphoma may 
have occurred in our patient during the preclinical phase of the disease [17]. Addi- 
tional genetic events may be responsible for the clinicopathologic evolution of NHL 
with the t(14;18), irrespective of whether or not they may be detectable cytogeneti- 
cally. Interestingly, the activation of c-myc by a complex cytagenetic rearrangement 
has recently been detected in a cell line established from a patient with Lyl lacking 
the classical 8;14 translocation [18]. Taken together, these observations possibly 
indicate that B-cell LyL may represent a histologic subset deriving in same cases from 
NHL of follicle center cell origin. Because current trends tend to unify treatment of 
LyL and of acute lymphoblastic leukemia [19], based on the notion that they may be 
similar clinicobiologic entities, the recognition of a disease subset of LyL possibly 
representing an evolutive form of follicle center cell NHL may crucial for the choice 
in such cases of a classical "anti lymphoma" therapy. 
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